HomeCOEP • NASDAQ
add
Coeptis Therapeutics Holdings Inc
Previous close
$0.35
Day range
$0.36 - $0.37
Year range
$0.29 - $2.19
Market cap
13.01M USD
Avg Volume
203.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.92M | -54.69% |
Net income | -3.00M | 61.85% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.67M | 56.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.03M | -51.15% |
Total assets | 9.39M | 58.09% |
Total liabilities | 5.03M | 8.13% |
Total equity | 4.36M | — |
Shares outstanding | 37.12M | — |
Price to book | 2.92 | — |
Return on assets | -83.66% | — |
Return on capital | -118.55% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -3.00M | 61.85% |
Cash from operations | -1.90M | -12.94% |
Cash from investing | -100.00K | — |
Cash from financing | 1.56M | — |
Net change in cash | -439.89K | 73.89% |
Free cash flow | -3.51M | -749.99% |
About
Founded
2017
Headquarters
Website
Employees
6